ISIS » Topics » Item 2. Properties

These excerpts taken from the ISIS 10-K filed Feb 26, 2009.

Item 2.  Properties

 

As of February 10, 2009, we occupied approximately 138,500 square feet of laboratory and office space, including a 28,704 square foot facility, which houses our manufacturing suites for our drug development business built to meet Good Manufacturing Practices.  We are located in four buildings in Carlsbad, California. We lease all of these buildings under lease agreements. The leases on the three buildings we primarily use for laboratory and office space for our drug development business expire in 2010, 2011 and 2012.  The leases that expire in 2010 and 2011 have two five-year options to extend the lease while the lease that expires in 2012 has one five-year option to extend the lease. The lease on the building we primarily use for our drug development manufacturing expires in 2020 and has two five-year options to extend the lease.

 

36



Item 2.  Properties

 

As of February 10, 2009, we occupied approximately 138,500 square feet of laboratory and office space, including a 28,704 square foot facility, which houses our manufacturing suites for our drug development business built to meet Good Manufacturing Practices.  We are located in four buildings in Carlsbad, California. We lease all of these buildings under lease agreements. The leases on the three buildings we primarily use for laboratory and office space for our drug development business expire in 2010, 2011 and 2012.  The leases that expire in 2010 and 2011 have two five-year options to extend the lease while the lease that expires in 2012 has one five-year option to extend the lease. The lease on the building we primarily use for our drug development manufacturing expires in 2020 and has two five-year options to extend the lease.

 

36



Item 2. 
Properties



 



As of February 10,
2009, we occupied approximately 138,500 square feet of laboratory and office
space, including a 28,704 square foot facility, which houses our manufacturing
suites for our drug development business built to meet Good Manufacturing
Practices.  We are located in four
buildings in Carlsbad, California. We lease all of these buildings under lease
agreements. The leases on the three buildings we primarily use for laboratory
and office space for our drug development business expire in 2010, 2011 and
2012.  The leases that expire in 2010 and
2011 have two five-year options to extend the lease while the lease that
expires in 2012 has one five-year option to extend the lease. The lease on the
building we primarily use for our drug development manufacturing expires in
2020 and has two five-year options to extend the lease.



 



36













Item 2. 
Properties



 



As of February 10,
2009, we occupied approximately 138,500 square feet of laboratory and office
space, including a 28,704 square foot facility, which houses our manufacturing
suites for our drug development business built to meet Good Manufacturing
Practices.  We are located in four
buildings in Carlsbad, California. We lease all of these buildings under lease
agreements. The leases on the three buildings we primarily use for laboratory
and office space for our drug development business expire in 2010, 2011 and
2012.  The leases that expire in 2010 and
2011 have two five-year options to extend the lease while the lease that
expires in 2012 has one five-year option to extend the lease. The lease on the
building we primarily use for our drug development manufacturing expires in
2020 and has two five-year options to extend the lease.



 



36













Item 2. 
Properties



 



As of February 10,
2009, we occupied approximately 138,500 square feet of laboratory and office
space, including a 28,704 square foot facility, which houses our manufacturing
suites for our drug development business built to meet Good Manufacturing
Practices.  We are located in four
buildings in Carlsbad, California. We lease all of these buildings under lease
agreements. The leases on the three buildings we primarily use for laboratory
and office space for our drug development business expire in 2010, 2011 and
2012.  The leases that expire in 2010 and
2011 have two five-year options to extend the lease while the lease that
expires in 2012 has one five-year option to extend the lease. The lease on the
building we primarily use for our drug development manufacturing expires in
2020 and has two five-year options to extend the lease.



 



36













These excerpts taken from the ISIS 10-K filed Mar 13, 2008.

Item 2.    Properties

        As of March 1, 2008, we occupied approximately 130,600 square feet of laboratory and office space, including a 28,704 square foot facility which houses our manufacturing suites for our drug development business built to meet Good Manufacturing Practices, and 12,900 square feet, which our Ibis subsidiary occupies, including 1,500 square feet of manufacturing area for Ibis' assay kits. We are located in three buildings in Carlsbad, California. We lease all of these buildings under lease agreements. The lease for the building that houses our Ibis business will expire in 2010 and has two five-year options to extend the lease. The lease on the building we primarily use for laboratory and office space for our drug development business will expire in 2012 and has a five-year option to extend the lease. The lease on the building we primarily use for our drug development manufacturing will expire in 2020 and has two five-year options to extend the lease.

        Subsequent to March 1, 2008, we entered into a lease for additional office and lab space for our drug development business. Initially, we will occupy approximately 9,500 square feet and in the second half of 2008, we will increase the space we occupy to approximately 23,700 square feet. The lease for this space expires in 2011 and has two five-year options to extend the lease.



Item 2.    Properties



        As of March 1, 2008, we occupied approximately 130,600 square feet of laboratory and office space, including a 28,704 square foot facility which houses our
manufacturing suites for our drug development business built to meet Good Manufacturing Practices, and 12,900 square feet, which our Ibis subsidiary occupies, including 1,500 square feet of
manufacturing area for Ibis' assay kits. We are located in three buildings in Carlsbad, California. We lease all of these buildings under lease agreements. The lease for the building that houses our
Ibis business will expire in 2010 and has two five-year options to extend the lease. The lease on the building we primarily use for laboratory and office space for our drug development
business will expire in 2012 and has a five-year option to extend the lease. The lease on the building we primarily use for our drug development manufacturing will expire in 2020 and has
two five-year options to extend the lease.



        Subsequent
to March 1, 2008, we entered into a lease for additional office and lab space for our drug development business. Initially, we will occupy approximately 9,500 square
feet and in the second half of 2008, we will increase the space we occupy to approximately 23,700 square feet. The lease for this space expires in 2011 and has two five-year options to
extend the lease.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki